Literature DB >> 8381447

Protein A antibody-capture ELISA (PACE): an ELISA format to avoid denaturation of surface-adsorbed antigens.

P K Ngai1, F Ackermann, H Wendt, R Savoca, H R Bosshard.   

Abstract

Adsorption to a polymeric surface may severely alter the antigenic structure of proteins through unfolding. A conventional capture ELISA in which a protein antigen is adsorbed to the microtiter plate may be unsuitable for testing the specificity of antibodies directed against native proteins (C. Schwab and H.R. Bosshard (1992) J. Immunol. Methods 147, 125). This problem can be overcome by PACE, a new ELISA procedure in which monoclonal or polyclonal antibodies are first allowed to equilibrate with biotinylated antigen in solution. Thereafter, the antigen-antibody complex (and free antibody) is bound to the microtiter plate through protein A. Captured antigen-antibody complex is detected by streptavidin-alkaline phosphatase and p-nitrophenylphosphate. A competition assay is accomplished by co-incubation of biotinylated and non-biotinylated antigens before capture to the protein A-coated plate. PACE combines the advantages of a solution-phase immunoassay (Farr assay) with the ease of a solid-phase ELISA. PACE has been used to test the conformational specificity of polyclonal and monoclonal antibodies against native and denatured cytochrome c, and of a polyclonal antiserum against a coiled coil leucine zipper peptide. Since a biotin group can be attached specifically to the N-terminal residue of synthetic peptides, PACE is also useful for assaying reactivity against peptide antigens which are difficult to adsorb to microtiter plates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381447     DOI: 10.1016/0022-1759(93)90223-t

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

Review 1.  Laboratory testing for heparin-induced thrombocytopenia.

Authors:  T E Warkentin
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

2.  Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assays.

Authors:  Rebecca A Brady; Anita Verma; Bruce D Meade; Drusilla L Burns
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

3.  Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display.

Authors:  Klervi Even-Desrumeaux; Damien Nevoltris; Marie Noelle Lavaut; Karima Alim; Jean-Paul Borg; Stéphane Audebert; Brigitte Kerfelec; Daniel Baty; Patrick Chames
Journal:  Mol Cell Proteomics       Date:  2013-12-20       Impact factor: 5.911

4.  Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener's granulomatosis.

Authors:  Zhenru Feng; Ping Liu; Zhiyan Li; Baohuan Sui
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

5.  Parallel evaluation of cell‑based phage display panning strategies: Optimized selection and depletion steps result in AML blast‑binding consensus antibodies.

Authors:  Theresa Weber; Sibylle Pscherer; Ulrike Gamerdinger; Andrea Teigler-Schlegel; Natalja Rutz; Wolfgang Blau; Mathias Rummel; Stefan Gattenlöhner; Mehmet Kemal Tur
Journal:  Mol Med Rep       Date:  2021-09-07       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.